Nadler: OpenEvidence used AI citations months before ChatGPT
Daniel Nadler · No Priors Ep. 130 | With OpenEvidence Founder Daniel Nadler · Sep 5, 2025 · at 8:23
OpenEvidence founder Daniel Nadler discusses early product differentiation against general-purpose AI chat engines.
0:00 / 0:05exact quote · 5.5s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“We were actually providing references and, Citations six months or nine months before ChatGPT started doing that.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Daniel Nadler
Nadler: OpenEvidence is used daily by 40% of US doctors
“We're used by 40% of doctors in the United States daily on average. It's about 20 times as much usage as the next thing that could be described as a clinical decision support platform.”
Nadler: Psychoanalyzing the trauma behind your motivation destroys your propulsion system
“I mean, I think there's a lot of truth to that except you don't want to go too close to that stuff because you'll actually kill the propulsion system in analyzing it.”
Nadler: Elite founders succeed through will to power, not rationalism
“I don't think if you build it, they will come is true. And nor would I say that, you know, Apple or Steve Jobs is a story if, that if you build it, they will come. To me, you know, Apple or Steve Jobs is a story that if you have extraordinary will to power And…”
Nadler: OpenEvidence is probably the only AI company in high-stakes clinical decisions
“We're probably the only company working at the tip of that spear. Most people have self-selected themselves out of the problem of high stakes, clinical decision-making certainly through an AI lens because they view it as ambitious.”
Nadler: Medical error is the third leading cause of US deaths
“It's well known, and it's been often repeated, that medical error is a third leading cause of death in the United States after heart disease and cancer.”
Nadler: OpenEvidence is NEJM's largest traffic referrer after Google
“You know, I think we're one of the largest sources of referral traffic to the England Journal of Medicine after Google. The rankings, I don't know if they're number two or three or four, but we're one of the largest sources of referral traffic to our partner i…”